Voleon Capital Management LP Buys New Shares in agilon health, inc. (NYSE:AGL)

Voleon Capital Management LP bought a new position in agilon health, inc. (NYSE:AGL - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 467,457 shares of the company's stock, valued at approximately $888,000. Voleon Capital Management LP owned approximately 0.11% of agilon health as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Schonfeld Strategic Advisors LLC boosted its position in agilon health by 102.1% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 88,503 shares of the company's stock valued at $168,000 after buying an additional 44,703 shares during the last quarter. Northern Trust Corp raised its stake in shares of agilon health by 13.0% during the 4th quarter. Northern Trust Corp now owns 2,962,350 shares of the company's stock valued at $5,628,000 after buying an additional 340,304 shares during the last quarter. Boothbay Fund Management LLC acquired a new position in shares of agilon health in the 4th quarter valued at about $58,000. Susquehanna Fundamental Investments LLC purchased a new stake in shares of agilon health in the fourth quarter worth about $1,616,000. Finally, Price T Rowe Associates Inc. MD grew its holdings in agilon health by 41.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company's stock worth $644,000 after acquiring an additional 98,377 shares during the period.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on AGL shares. JMP Securities restated a "market perform" rating on shares of agilon health in a research report on Monday, April 28th. Citigroup upgraded shares of agilon health from a "neutral" rating to a "buy" rating and raised their price target for the company from $3.25 to $5.00 in a research report on Friday, April 25th. Robert W. Baird cut their price target on agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Finally, Royal Bank of Canada boosted their price objective on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $4.81.

agilon health Trading Down 1.3 %

NYSE:AGL traded down $0.06 during trading hours on Monday, hitting $4.11. The company had a trading volume of 3,618,842 shares, compared to its average volume of 4,857,049. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a 50-day moving average of $4.23 and a 200 day moving average of $3.16. The company has a market cap of $1.70 billion, a P/E ratio of -4.37 and a beta of 0.38.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.